Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of D-2570 in Hepatic Impairment and Normal Hepatic Function
NCT07715149Phase 1Recruiting
- Sponsor
- InventisBio
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of D-2570 in psoriasis (3 arms), sponsored by InventisBio. Primary endpoints: Time to maximum measured plasma concentration up to 192 hours, Maximum observed plasma concentration up to 192 hours and 4 more. Started Jul 2026; status: recruiting.
02
Drugs
D-2570
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07715149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07715149.